Regernon antibiody cocktail effective at treating mild to moderate cases of COVID-19
Regeneron’s antibody cocktail that Trump hailed as ‘key’ to his speedy recovery cuts risk of COVID hospitalization and death by 70%, trial data show.
Regeneron’s coronavirus antibody cocktail is effective at treating mild to moderate cases of COVID-19, new late-stage trial results suggest.
The treatment is a mixture of drugs casirivimab and imdevimab, and was developed by the New York City-based company in partnership with pharmaceutical firm Roche.
Known as REGEN-COV, the cocktail imitates antibodies that the body generates when fighting the virus in order to boost the immune system.
https://populist.press/trump-was-right-now-democrats-silent/